Literature DB >> 12624729

Identification of a novel human angiopoietin-like gene expressed mainly in heart.

Li Zeng1, Jianliang Dai, Kang Ying, Enpeng Zhao, Wei Jin, Yin Ye, Jianfeng Dai, Jian Xu, Yi Xie, Yumin Mao.   

Abstract

The angiopoietins are an important family of growth factors specific for vascular endothelium. Most of them bind to the TIE2 receptor and are related to regulation of angiogenesis. During large-scale DNA sequencing of the human fetal brain cDNA library, we cloned a novel human angiopoietin-like cDNA and termed it human angiopoietin-like 5 ( ANGPTL5). Like other members of the angiopoietin family, ANGPTL5-deduced protein also has an N-terminal cleavable signal peptide, a predicted coiled-coil domain, and a fibrinogen-like domain. The search against the human genome database indicated that ANGPTL5 maps to 11q22. Expression analysis of ANGPTL5 shows that it is mainly expressed in adult human heart.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624729     DOI: 10.1007/s100380300025

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

1.  An efficient and flexible test for rare variant effects.

Authors:  Shonosuke Sugasawa; Hisashi Noma; Takahiro Otani; Jo Nishino; Shigeyuki Matsui
Journal:  Eur J Hum Genet       Date:  2017-04-12       Impact factor: 4.246

2.  Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders.

Authors:  Marco Bruno Morelli; Christopher Chavez; Gaetano Santulli
Journal:  Expert Opin Ther Targets       Date:  2020-01-15       Impact factor: 6.902

3.  Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells.

Authors:  Cheng Cheng Zhang; Megan Kaba; Guangtao Ge; Kathleen Xie; Wei Tong; Christopher Hug; Harvey F Lodish
Journal:  Nat Med       Date:  2006-01-22       Impact factor: 53.440

4.  Angiopoietin-like gene expression in the mouse uterus during implantation and in response to steroids.

Authors:  Charles A Scott; Doan van Huyen; Brent M Bany
Journal:  Cell Tissue Res       Date:  2012-02-22       Impact factor: 5.249

5.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

Authors:  Stefano Romeo; Wu Yin; Julia Kozlitina; Len A Pennacchio; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

6.  Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation.

Authors:  Cheng Cheng Zhang; Megan Kaba; Satoru Iizuka; HoangDinh Huynh; Harvey F Lodish
Journal:  Blood       Date:  2008-01-17       Impact factor: 22.113

7.  Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers.

Authors:  Noriko Tonomura; Ingegerd Elvers; Rachael Thomas; Kate Megquier; Jason Turner-Maier; Cedric Howald; Aaron L Sarver; Ross Swofford; Aric M Frantz; Daisuke Ito; Evan Mauceli; Maja Arendt; Hyun Ji Noh; Michele Koltookian; Tara Biagi; Sarah Fryc; Christina Williams; Anne C Avery; Jong-Hyuk Kim; Lisa Barber; Kristine Burgess; Eric S Lander; Elinor K Karlsson; Chieko Azuma; Jaime F Modiano; Matthew Breen; Kerstin Lindblad-Toh
Journal:  PLoS Genet       Date:  2015-02-02       Impact factor: 5.917

8.  Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells.

Authors:  Ryuta Sato; Mutsushi Yamasaki; Kenichi Hirai; Takanori Matsubara; Takeo Nomura; Fuminori Sato; Hiromitsu Mimata
Journal:  Oncol Rep       Date:  2014-11-03       Impact factor: 3.906

Review 9.  Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway.

Authors:  Laura La Paglia; Angela Listì; Stefano Caruso; Valeria Amodeo; Francesco Passiglia; Viviana Bazan; Daniele Fanale
Journal:  PPAR Res       Date:  2017-01-15       Impact factor: 4.964

Review 10.  Angiopoietin-like proteins: a comprehensive look.

Authors:  Gaetano Santulli
Journal:  Front Endocrinol (Lausanne)       Date:  2014-01-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.